$VMCA
Valuence Merger Corp I Stock $vmca

$vmca Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224046053 Filed on November 14, 2024

Income Statement

Concept	2024 Q3	2023 Q3
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$235.6K
YoY Change		-75.17%
Operating Profit	-$203.1K	-$235.6K
YoY Change	-13.78%	-75.17%
Interest Expense		$865.4K
YoY Change		-18.32%
% of Operating Profit
Other Income/Expense, Net	$238.2K	$865.4K
YoY Change	-72.48%	-18.32%
Pretax Income		$629.8K
YoY Change		469.98%
Income Tax
% Of Pretax Income
Net Earnings	$35.03K	$629.8K
YoY Change	-94.44%	469.96%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share		$0.05
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$624.9K
YoY Change		34.88%
Cash & Equivalents	$15.54K	$624.8K
Short-Term Investments
Other Short-Term Assets		$209.6K
YoY Change		-67.33%
Inventory
Prepaid Expenses	$88.27K	$209.6K
Receivables
Other Receivables
Total Short-Term Assets	$103.8K	$834.4K
YoY Change	-87.56%	-24.46%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$67.94M
YoY Change		-70.21%
Other Assets
YoY Change
Total Long-Term Assets	$21.92M	$67.94M
YoY Change	-67.73%	-70.21%
TOTAL ASSETS
Total Short-Term Assets	$103.8K	$834.4K
Total Long-Term Assets	$21.92M	$67.94M
Total Assets	$22.02M	$68.77M
YoY Change	-67.97%	-69.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$2.422M
YoY Change		122.19%
Accrued Expenses		$0.00
YoY Change		-100.0%
Deferred Revenue
YoY Change
Short-Term Debt		$1.458M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.659M	$4.079M
YoY Change	38.73%	200.21%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$8.105M
YoY Change		0.0%
Total Long-Term Liabilities		$8.105M
YoY Change		0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.659M	$4.079M
Total Long-Term Liabilities		$8.105M
Total Liabilities	$13.76M	$12.18M
YoY Change	12.97%	28.74%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.66M	-$11.35M
YoY Change	20.36%	35.77%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$13.66M	-$11.35M
YoY Change
Total Liabilities & Shareholders Equity	$22.02M	$68.77M
YoY Change	-67.97%	-69.99%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	$35.03K	$629.8K
YoY Change	-94.44%	469.96%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		-$173.8K
YoY Change		113.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$140.0K
YoY Change
Cash From Investing Activities		-$140.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		820.2K
YoY Change
NET CHANGE
Cash From Operating Activities		-173.8K
Cash From Investing Activities		-140.0K
Cash From Financing Activities		820.2K
Net Change In Cash		506.4K
YoY Change		-721.3%
FREE CASH FLOW
Cash From Operating Activities		-$173.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5258992	usd
	us-gaap	Net Income Loss NetIncomeLoss	792407	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001892747
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	88267	usd
CY2024Q3	us-gaap	Assets Assets	22024639	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2471034	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5658566	usd
CY2024Q3	us-gaap	Liabilities Liabilities	13764046	usd
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	21920833	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13660790	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-13660240	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22024639	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q3	us-gaap	Cash Cash	15539	usd
CY2024Q3	VMCA	Working Capital Loans WorkingCapitalLoans	613207	usd
CY2024Q3	VMCA	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	8105480	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	203143	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	235620	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	926412	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-203143	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-235620	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-926412	usd
CY2024Q3	VMCA	Interest Earned On Cash And Investments Held In Trust Account InterestEarnedOnCashAndInvestmentsHeldInTrustAccount	238177	usd
CY2023Q3	VMCA	Interest Earned On Cash And Investments Held In Trust Account InterestEarnedOnCashAndInvestmentsHeldInTrustAccount	865386	usd
	VMCA	Interest Earned On Cash And Investments Held In Trust Account InterestEarnedOnCashAndInvestmentsHeldInTrustAccount	1718819	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	238177	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	865386	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1718819	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	35034	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	629766	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11893772	usd
CY2024Q1	VMCA	Accretion Of Ordinary Shares Subject To Possible Redemption AccretionOfOrdinarySharesSubjectToPossibleRedemption	-1266149	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	588681	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-12571240	usd
CY2024Q2	VMCA	Accretion Of Ordinary Shares Subject To Possible Redemption AccretionOfOrdinarySharesSubjectToPossibleRedemption	-970515	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	168692	usd
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41304
	dei	Entity Registrant Name EntityRegistrantName	VALUENCE MERGER CORP. I
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4 Orinda Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100D
	dei	Entity Address City Or Town EntityAddressCityOrTown	Orinda
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94563
	dei	City Area Code CityAreaCode	(415)
	dei	Local Phone Number LocalPhoneNumber	340-0222
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q4	us-gaap	Cash Cash	684816	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	78070	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	103806	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	762886	usd
CY2024Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	21920833	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	69402338	usd
CY2023Q4	us-gaap	Assets Assets	70165224	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2228646	usd
CY2023Q4	VMCA	Working Capital Loans WorkingCapitalLoans	613207	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4691178	usd
CY2023Q4	VMCA	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	8105480	usd
CY2023Q4	us-gaap	Liabilities Liabilities	12796658	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	69262338	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11894322	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11893772	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	70165224	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1268085	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1268085	usd
	VMCA	Interest Earned On Cash And Investments Held In Trust Account InterestEarnedOnCashAndInvestmentsHeldInTrustAccount	5258992	usd
	us-gaap	Net Income Loss NetIncomeLoss	3990907	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-13373063	usd
CY2024Q3	VMCA	Accretion Of Ordinary Shares Subject To Possible Redemption AccretionOfOrdinarySharesSubjectToPossibleRedemption	-322211	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	35034	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-13660240	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9521688	usd
CY2023Q1	VMCA	Accretion Of Ordinary Shares Subject To Possible Redemption AccretionOfOrdinarySharesSubjectToPossibleRedemption	-2430776	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1776101	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-10176363	usd
CY2023Q2	VMCA	Accretion Of Ordinary Shares Subject To Possible Redemption AccretionOfOrdinarySharesSubjectToPossibleRedemption	-2382830	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1585040	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-10974153	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-10974153	usd
CY2023Q3	VMCA	Accretion Of Ordinary Shares Subject To Possible Redemption AccretionOfOrdinarySharesSubjectToPossibleRedemption	-1005386	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	629766	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-11349773	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-11349773	usd
	us-gaap	Net Income Loss NetIncomeLoss	792407	usd
	us-gaap	Net Income Loss NetIncomeLoss	3990907	usd
	VMCA	Interest Earned On Cash And Investments Held In Trust Account InterestEarnedOnCashAndInvestmentsHeldInTrustAccount	1718819	usd
	VMCA	Interest Earned On Cash And Investments Held In Trust Account InterestEarnedOnCashAndInvestmentsHeldInTrustAccount	5258992	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	10197	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-312864	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	242387	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	432907	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-694222	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-522314	usd
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	700055	usd
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	560000	usd
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	49900380	usd
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	167831206	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	49200325	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	167271206	usd
	VMCA	Proceeds From Convertible Promissory Note Related Party ProceedsFromConvertiblePromissoryNoteRelatedParty	300000	usd
	VMCA	Proceeds From Convertible Promissory Note Related Party ProceedsFromConvertiblePromissoryNoteRelatedParty	172714	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1285246	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	425000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	70000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	49900380	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	167831206	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-49175380	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-166443246	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-669277	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	305646	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	684816	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	319201	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15539	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	624847	usd
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2022Q1	us-gaap	Deposits Deposits	20702619	usd
CY2022Q1	VMCA	Deposits Per Unit DepositsPerUnit	10.30
CY2022Q1	VMCA	Proceeds From Deposit In Trust Account ProceedsFromDepositInTrustAccount	226702619	usd
	VMCA	Transaction Costs TransactionCosts	10718994	usd
	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	4000000	usd
	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	2200996	usd
	VMCA	Deferred Underwriting Fees DeferredUnderwritingFees	8105480	usd
CY2024Q3	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	814510	usd
CY2021Q4	us-gaap	Sponsor Fees SponsorFees	25000	usd
CY2021Q4	VMCA	Sponsor Fees And Valuence Share SponsorFeesAndValuenceShare	5502490	usd
CY2024Q3	VMCA	Percentage Of Fair Market Value PercentageOfFairMarketValue	0.80	pure
CY2024Q3	VMCA	Percentage Of Public Shares That Can Be Transferred Without Any Restriction PercentageOfPublicSharesThatCanBeTransferredWithoutAnyRestriction	0.15	pure
CY2024Q3	VMCA	Public Shares Redeem Percentage PublicSharesRedeemPercentage	1	pure
CY2024Q3	us-gaap	Share Price SharePrice	10.00
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	420000	usd
	VMCA	Payments For Additional Contribution Amount PaymentsForAdditionalContributionAmount	140000	usd
CY2024Q3	us-gaap	Minimum Net Worth Required For Compliance MinimumNetWorthRequiredForCompliance	5000001	usd
CY2024Q3	us-gaap	Minimum Net Worth Required For Compliance MinimumNetWorthRequiredForCompliance	5000001	usd
CY2024Q1	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	100000000000	usd
CY2024Q2	VMCA	Reedemable Share Based Allocation Description ReedemableShareBasedAllocationDescription	(i) on June 4, 2024, with respect to the initial extension, an amount equal to the lesser of (x) $60,000 or (y) $0.03 per public share multiplied by the number of Public Shares outstanding and (ii) one business day following the public announcement by the Company that the Board of Directors has elected to further extend such date for an additional month, an amount equal to the lesser of (x) $30,000 or (y) $0.015 per public share multiplied by the number of Public Shares outstanding (the “New Contributions”)
CY2024Q2	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.099	pure
CY2024Q2	us-gaap	Deposits Deposits	56022	usd
CY2024Q3	us-gaap	Deposits Deposits	28011	usd
CY2024Q3	us-gaap	Deposits Deposits	28011	usd
CY2024Q3	us-gaap	Deposits Deposits	28011	usd
CY2024Q3	us-gaap	Cash Cash	15539	usd
CY2024Q3	VMCA	Working Capital Deficit WorkingCapitalDeficit	5554762	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zTpG0XmEnAD5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Cash Cash	15539	usd
CY2023Q4	us-gaap	Cash Cash	684816	usd
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q2	us-gaap	Payments For Deposits PaymentsForDeposits	56022	usd
CY2024Q3	us-gaap	Payments For Deposits PaymentsForDeposits	28011	usd
CY2024Q3	us-gaap	Payments For Deposits PaymentsForDeposits	28011	usd
CY2024Q3	us-gaap	Payments For Deposits PaymentsForDeposits	28011	usd
CY2024Q4	us-gaap	Payments For Deposits PaymentsForDeposits	84033	usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	220099630	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	5942690	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-10393817	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	26186866	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	229949989	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	167831206	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	7143555	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	69262338	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	1266149	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	70528487	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	49900380	usd
CY2024Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	970515	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	21598622	usd
CY2024Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	322211	usd
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	21920833	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q3	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zgzbE7DWhOFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration of Credit Risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20240930_z9TK0Fjrr8N" title="Federal deposit insurance corporation coverage limit">250,000</span>. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2021Q4	us-gaap	Sponsor Fees SponsorFees	25000	usd
	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	(A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	1500000	usd
CY2022Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	198384	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	170000	usd
CY2024Q2	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	255000	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2024Q3	VMCA	Equity Proceeds Percentage EquityProceedsPercentage	0.60	pure
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price

Files In Submission

Name	View Source	Status
0001493152-24-046053-index-headers.html	Edgar Link	pending
0001493152-24-046053-index.html	Edgar Link	pending
0001493152-24-046053.txt	Edgar Link	pending
0001493152-24-046053-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vmca-20240930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
vmca-20240930_cal.xml	Edgar Link	unprocessable
vmca-20240930_def.xml	Edgar Link	unprocessable
vmca-20240930_lab.xml	Edgar Link	unprocessable
vmca-20240930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VMCA
Valuence Merger Corp I Stock $vmca

2024 Q3 Form 10-Q Financial Statement

#000149315224046053 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VMCA Valuence Merger Corp I Stock $vmca

2024 Q3 Form 10-Q Financial Statement

#000149315224046053 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VMCA
Valuence Merger Corp I Stock $vmca